Published in

Cell Press, Chemistry and Biology, 1(19), p. 116-129, 2012

DOI: 10.1016/j.chembiol.2012.01.004

Links

Tools

Export citation

Search in Google Scholar

Global Phenotypic Screening for Antimalarials

Journal article published in 2012 by W. Armand Guiguemde, W. Armand Guiguemde, Anang A. Shelat, Jose F. Garcia-Bustos ORCID, Thierry T. Diagana, Francisco-Javier Gamo, R. Kiplin Guy ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Malaria, a devastating infectious disease caused by Plasmodium spp., leads to roughly 655,000 deaths per year, mostly of African children. To compound the problem, drug resistance has emerged to all classical antimalarials and may be emerging for artemisinin-based combination therapies. To address the need for new antimalarials with novel mechanisms, several groups carried out phenotypic screening campaigns to identify compounds inhibiting growth of the blood stages of Plasmodium falciparum. In this review, we describe the characterization of these compounds, explore currently ongoing strategies to develop lead molecules, and endorse the concept of a “malaria box” of publicly accessible active compounds.